SBI Pharma Fund - Direct (D)

Fund Class : Equity - Pharma
Fund House : SBI Mutual Fund
Aum(Rs Cr) : 65.14
NAV 18 Oct 2017 109.75 -0.47
(-0.43%)

NAV High-Low (in Rs)

ONE Mth 1001.45
1001.45
52-WEEk 847.18
1082.59

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.57 2.01 - - 7.5
Sensex 0.65 -0.04 10.41 15.74 24.06
Nifty 0.5 -0.01 11.46 17.18 30.42

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 65.14 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Tanmaya Desai

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Sep 2017
Category Share (%)
Cash & Bank Balance & Bank Deposits 0.03
CBLO 4.07
Equity 95.98
› More
   As On 30 Sep 2017
Sector Name Amount
Healthcare 12.71
NA 4.10
Pharmaceuticals - Indian - Bulk Drugs 17.23
Pharmaceuticals - Indian - Bulk Drugs & Formln 55.36
Pharmaceuticals - Indian - Formulations 7.55
Pharmaceuticals - Multinational 3.13
› More
   As On 30 Sep 2017
Company Name
Divi's Lab. 10.25
Cipla 10.07
Aurobindo Pharma 9.32
Strides Shasun 7.96
Dr Reddy's Labs 5.58
Natco Pharma 5.03
Cadila Health. 4.70
Alkem Lab 4.60
› More

Fund DETAILS

Asset Management Co.

Registered Address

SBI Funds Management Ltd,

9th floorCrescenzoC-39&39
G BlockBandra-kurla complex
Bandra (east)Mumbai-400 051.

Phone: 022-61793000 | Fax: 022-2218 9663

Email: partnerforlife@sbimf.com

Website: www.sbimf.com